Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berlin

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2023
The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancerAdriano Basso Dias, Seyed Ali Mirshahvalad, Claudia Ortega, et al.
Urologic Oncology|April 8, 2022
The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancerLouise C McLoughlin, Sophie O'Halloran, Michael Tjong, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 2, 2023
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapyWinnie Li, Jerusha Padayachee, Inmaculada Navarro, et al.
European Urology Focus|June 2, 2023
Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform DiseaseRui Bernardino, Rashid K Sayyid, Zizo Al-Daqqaq, et al.
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 19, 2017
Management and Outcomes in the Oldest-Old Population with GlioblastomaFabio Y Moraes, Andrea Lo, Erin R Morgan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2025
Clinician perceptions of asynchronous care for patients with ovarian cancer on PARP inhibitor therapyMelissa Kozak, Ainhoa Madariaga, Yuliya Gavrylyuk, et al.
Urologic Oncology|June 27, 2017
Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysisAlejandro Berlin, Julio F Castro-Mesta, Laura Rodriguez-Romo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Clinical Genitourinary Cancer|January 29, 2019
Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder CancerDi Maria Jiang, Haiyan Jiang, Peter W M Chung, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2023
The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancerAdriano Basso Dias, Seyed Ali Mirshahvalad, Claudia Ortega, et al.
Urologic Oncology|April 8, 2022
The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancerLouise C McLoughlin, Sophie O'Halloran, Michael Tjong, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 2, 2023
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapyWinnie Li, Jerusha Padayachee, Inmaculada Navarro, et al.
European Urology Focus|June 2, 2023
Lymphotropic Pattern of Prostate-specific Membrane Antigen-detected Metastases Among Biochemically Recurrent Radical Prostatectomy Patients with Cribriform DiseaseRui Bernardino, Rashid K Sayyid, Zizo Al-Daqqaq, et al.
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 19, 2017
Management and Outcomes in the Oldest-Old Population with GlioblastomaFabio Y Moraes, Andrea Lo, Erin R Morgan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2025
Clinician perceptions of asynchronous care for patients with ovarian cancer on PARP inhibitor therapyMelissa Kozak, Ainhoa Madariaga, Yuliya Gavrylyuk, et al.
Urologic Oncology|June 27, 2017
Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysisAlejandro Berlin, Julio F Castro-Mesta, Laura Rodriguez-Romo, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Clinical Genitourinary Cancer|January 29, 2019
Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder CancerDi Maria Jiang, Haiyan Jiang, Peter W M Chung, et al.
Pageof 23